ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 049,19
-0,20%
Dow Jones
38 386,09
0,38%
DAX
18 048,54
-0,46%
Brent Oil
87,315
0,03%
Bitcoin
61 592,29
-3,52%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Alvontech (ALVO)

  7. Alvontech (ALVO) Actualités

ALVO Alvontech

14,22
0,00 (0,00%)
Avant marché
Dernière mise à jour : 11:44:07
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Alvontech ALVO NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 14,22 11:44:07
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
14,22
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
30/4/202410:00GLOBEU.S. Commercialization Agreement with Quallent to Drive..
24/4/202410:00GLOBEAlvotech Announces Topline Results from a Confirmatory..
19/4/202412:10GLOBEAlvotech signs U.S. agreement to expand access for newly..
16/4/202423:43BWAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
16/4/202423:30GLOBEAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
03/4/202413:41GLOBEAlvotech Hosts Audio Call for Investors at 8:15 am EDT on..
22/3/202421:15GLOBEAlvotech Announces Increase in Number of Own Shares
20/3/202421:15GLOBEAlvotech Reports Financial Results for Full Year 2023 and..
20/3/202412:17IHMARKETNEWSU.S. Index Futures Trade Sideways Amid Anticipation of Fed’s..
05/3/202422:00GLOBEAlvotech Announces Webcast of Full Year 2023 Financial..
29/2/202422:05GLOBEAlvotech Appoints Interim Chief Quality Officer
26/2/202410:25GLOBEAlvotech Accepts Offer for the Sale of Shares for a value of..
24/2/202402:15GLOBEAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
24/2/202402:15BWAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
15/2/202412:30GLOBEAlvotech Announces Expected Global Market Entry Dates for..
29/1/202410:00GLOBEAlvotech Announces Positive Top-Line Results from a..
19/1/202418:31DJNAlvotech Shares Climb After FDA Concludes Facility..
19/1/202417:30GLOBEAlvotech Provides Update on Status of Biologics License..
10/1/202409:30GLOBESTADA and Alvotech secure approval for Uzpruvo, Europe’s..
03/1/202409:30GLOBEAlvotech Clinical Study Results Demonstrate Therapeutic..
29/11/202310:00GLOBEAlvotech Announces Positive Top-Line Results from a..
28/11/202322:15GLOBEAlvotech Reports Financial Results for First Nine Months of..
21/11/202314:00GLOBEAlvotech to Report Financial Results for the First Nine..
14/11/202313:00GLOBEAlvotech and JAMP Pharma Announce Receipt of Marketing..
10/11/202315:30GLOBESTADA and Alvotech receive positive CHMP opinion for..
07/11/202314:00GLOBEAlvotech to Present at the Jefferies 2023 London Healthcare..
12/10/202310:00GLOBEAlvotech Provides Update on Status of U.S. Biologics License..
03/10/202314:29BWKashiv BioSciences Enters into Exclusive Licensing Agreement..
03/10/202311:00GLOBEAlvotech Enters into Exclusive Licensing Agreement with..
25/9/202310:00GLOBEAlvotech Announces Approval in Japan of AVT04 (ustekinumab),..
20/9/202310:30GLOBEAlvotech Provides U.S. Regulatory Update on AVT02, a..
05/9/202315:30GLOBEAlvotech Announces Changes to the Leadership Team
30/8/202322:15GLOBEAlvotech Reports Financial Results for First Six Months of..
29/8/202311:00GLOBEAlvotech and Bioventure Announce Approval of AVT02..
22/8/202315:15GLOBEAlvotech to Report Financial Results for the First Half of..
31/7/202310:00GLOBEAlvotech Completes $100 Million Convertible Bond Private..
24/7/202310:00GLOBETeva Pharmaceuticals and Alvotech Provide Update on..
03/7/202315:37DJNAlvotech Shares Rebound 20% After FDA Letter Selloff
29/6/202302:03DJNAlvotech Gets FDA Letter, Expects Delay in U.S. Approval of..
29/6/202301:00GLOBEAlvotech Provides Regulatory Update on Second Biologics..
12/6/202313:00BWAlvotech and Teva Secure U.S. License Date for AVT04, a..
12/6/202309:00GLOBEAlvotech and Teva Secure U.S. License Date for AVT04, a..
31/5/202311:20GLOBEAlvotech to Participate in Jefferies Healthcare Conference
24/5/202311:00GLOBEAlvotech and Advanz Pharma extend strategic partnership to..
19/5/202311:00GLOBEAlvotech Reports Financial Results for First three Months of..
17/5/202311:00GLOBEAlvotech to Participate in Morgan Stanley Annual..
15/5/202311:00GLOBEAlvotech Issues Annual Equality Report Covering 2022
10/5/202311:00GLOBEAlvotech enters into commercialization agreement with..
04/5/202311:00GLOBEAlvotech Initiates Confirmatory Patient Study for AVT05, a..
03/5/202315:00GLOBEAlvotech to Report First Quarter 2023 Financial Results and..

Dernières Valeurs Consultées

NASDAQ
ALVO
Alvontech
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés